CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change intervention

• Published in: BMJ open 2023-08, Vol.13 (8), p.e075795-e075795
• Main Authors: Scott, Sion, Atkins, Bethany, Martin-Kerry, Jacqueline M, Pritchard, Megan, Alldred, David Phillip, Clark, Allan B, Colles, Antony, Hammond, Amber, Murphy, Katherine, Keevil, Victoria L, Kellar, Ian, Patel, Martyn, Sims, Erika, Taylor, Johanna, Turner, David, Witham, Miles, Wright, David, Bhattacharya, Debi
• Format: Article
• Language: English
• Subjects: Aged; Consent; Data collection; Deprescriptions; Drug stores; Feasibility Studies; Geriatric Medicine; Geriatricians; Geriatrics; Hospitals; Humans; Intervention; Medical personnel; Medication Review; Medicine; Older people; Pharmacists; Professionals; Quality of Life; R&D; Research & development
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-075795

Over 50% of older adults are prescribed a medicine where the risk of harm outweighs the chances of benefit. During a hospital admission, older adults and carers expect medicines to be reviewed for appropriateness and any inappropriate medicines proactively deprescribed. While the principle of proactive deprescribing is an expectation of good prescribing practice, it is yet to become routine. The CompreHensive geriAtRician-led MEdication Review (CHARMER) study aims to develop and test a five-component behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe inappropriate medicines with older adults in hospital. This study aims to test the feasibility and acceptability of study processes and CHARMER implementation. A two-arm purposive allocation feasibility study is being undertaken at four acute hospitals in England, UK (three intervention and one control). The target sample is 400 patients across all hospitals. Primary outcome measures are: (1) participant recruitment rate and (2) participant attrition rate. Secondary outcome measures are: (1) hospital readmission rate; (2) mortality rate and (3) quality of life. Quantitative data will be checked for completeness and quality, and practitioner and patient demographics descriptively analysed. We will undertake a rapid qualitative analysis on observations, interviews and study meeting minutes data. A subsequent thematic analysis will be undertaken with codes mapped to the Theoretical Domains Framework and Normalisation Process Theory. Triangulation of qualitative and quantitative data will be undertaken. Ethics approval was obtained from Wales Research Ethics Committee 1 (IRAS ID 312494) and study approval from the Health Research Authority (22/WA/0087). Informed consent will be sought from all hospital staff involved in data collection activities and for patients involved in enhanced data collection activities. The findings of this study will be disseminated in peer-reviewed journals and conference presentations. ISRCTN11899506.